DA Davidson Maintains Neutral on Teladoc Health, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
DA Davidson analyst Gil Luria maintains a Neutral rating on Teladoc Health (NYSE:TDOC) and lowers the price target from $12 to $8.
August 01, 2024 | 3:23 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
DA Davidson analyst Gil Luria maintains a Neutral rating on Teladoc Health and lowers the price target from $12 to $8.
The lowered price target from $12 to $8 by DA Davidson suggests a negative outlook on Teladoc Health's stock performance. This could lead to a short-term decline in the stock price as investors react to the reduced target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100